Decision Advisory for Biotech Leaders
As an owner-managed Swiss advisory boutique, we support biotech and pharma companies in valuation-driven strategic decisions, partnering and transactions.
We combine industry understanding and hands-on transaction experience with advanced financial modelling to help management teams navigate the value inflection points that shape their company's future.
Our Services
Partnering and M&A Advisory
We support biotech and pharma companies in preparing and executing partnering and transaction processes, including:
-
Buy-side and sell-side M&A support, from deal sourcing to closing
-
Identification of target companies, licensing partners and pipeline assets
-
In- and out-licensing strategy and execution
-
Opportunity assessment and due diligence support
-
Deal structuring and negotiation guidance
Valuation and Decision Analytics
We apply advanced valuation and multi-scenario modelling to quantify uncertainty and support high-stakes decisions:
-
Risk-adjusted Net Present Value (rNPV) of companies and assets
-
Multi-scenario modelling across clinical and commercial outcomes
-
Sensitivity analysis to identify key value drivers
-
Monte Carlo simulations for probabilistic value assessment
Why Ocean21
We are a boutique advisory – and that is your advantage.
Valuation-driven Decision Making
We combine advanced valuation, multi-scenario modelling and quantify uncertainty to structure decisions and transactions.
Deep Biotech Understanding
We understand the scientific, regulatory and commercial drivers of value across biotech assets and portfolios.
C-Level Perspective
We work with founders, executives and investors on high-stakes decisions and transactions.
Your Experts
Partner
Mischa Csendes
With over 20 years of experience as an entrepreneur, in business development roles at Big Pharma, and in various commercial positions across listed companies and start-ups, Mischa brings a unique combination of strategic thinking and hands-on industry knowledge. He is passionate about the Pharmaceutical and Biotech industry and offers a strong understanding of its complex business dynamics. At Ocean21, Mischa advises clients on strategy development, partner identification, key transactions, and financial valuation.
.jpg)
Partner
Ben Kohler
As a goal-driven entrepreneur with more than 15 years of CFO, Controlling and Business Development experience, Ben brings strong analytical thinking, hands-on operational expertise, and proven M&A experience to Ocean21. Leveraging advanced technical skills and a deep understanding of financial dynamics, he adds structure and clarity to complex valuation scenarios and translates numbers into insights that clients can act on.
Partner
Dr. Ivan Csendes
With over 35 years of experience in pharmaceutical business development, Ivan brings deep expertise in licensing, strategic partnering, and deal-making. He held senior roles at Novartis and later advised biotech and pharma companies across Europe. As a strong networker, Ivan is the Co-founder and past president of the Swiss Pharma Licensing Group and a past president of the European Pharma Licensing Council. He has also served on multiple Biotech boards, including as chairman, bringing strategic insight and hands-on governance experience to Ocean21 clients.
Our Network
We work with a network of senior industry experts and advisors to complement our core team where needed. This allows us to bring in specialized expertise, for example in pricing, market access or due diligence, while maintaining a focused and senior advisory approach.
About Ocean21
At Ocean21, our name defines our philosophy. Ocean symbolizes the depth, constant movement, and global interconnectivity of the biotech and pharma industries. We navigate these complexities daily, turning industry uncertainty into a competitive advantage.
21 represents the 21st century - an era of rapid medical innovation, technological progress, and global challenges. Together, Ocean21 is our commitment to guiding life science decision-makers through valuation-driven decisions, partnering and transactions with entrepreneurial thinking and analytical precision.
From multi-scenario biotech company valuations to strategic partner identification as well as complex M&A and licensing transactions, we provide the support you need.
With deep industry expertise, entrepreneurial insight, and analytical precision, we deliver a clear, execution-focused approach to every engagement.
Ocean21 GmbH
Nidelbadstrasse 65, 8038 Zürich, Switzerland | contact@ocean21.ch
CHE-134.891.823
Designed by Muriel Imfeld